New Drug Reduces Heart Damage

Monday, 11 Mar 2013 12:26 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
A single dose of an experimental anti-inflammatory treatment reduces heart muscle damage during an angioplasty operation to open blocked arteries, a study found Sunday.
 
The antibody inclacumab, developed by Swiss lab Hoffmann-La Roche, significantly reduced levels of the standard molecular markers troponin I and CK-MB in patients, compared to those who took a placebo in a clinical trial.
 
Patients who received the inclacumab dose saw troponin I levels drop 22.4 percent more after 16 hours and 24.4 percent after more at 24 hours (p=0.05), compared with patients on a placebo.
 
CK-MB levels dropped 16.3 percent more after 16 hours and 17.4 percent more at 24 hours, compared with patients on placebo.
 
"It was exciting to see that a single administration of inclacumab would yield clinical benefit," said the study's lead investigator Jean-Claude Tardif, director of the Research Center at the Montreal Heart Institute.
 
The phase II trial examined 530 patients with a median age of 61 experiencing a type of heart attack called non-ST-elevation myocardial infarction or NSTEMI.
 
Patients were randomized to receive an infusion of inclacumab of 20 milligrams per kilogram, five milligrams per kilogram or a placebo one hour before angioplasty.
 
The researchers also found that 24 hours after angioplasty, 18.3 percent of patients on the placebo had CK-MB increases more than three times the upper limit of normal.
 
Many clinical trials define that threshold as the onset of a post-angioplasty heart attack.
But only 8.9 percent of patients who received the higher dose of inclacumab experienced those same CK-MB increases.
 
"If we're able to confirm these results in potential future studies, this drug could become part of the therapeutic armamentarium in modern cardiology," Tardif said in a statement.
"You could use this drug more widely, in all patients coming in with heart attacks, although that would require additional large studies."
 
More than a million coronary angioplasty procedures are performed in the United States each year, costing more than $10 billion.
 
Angioplasty can damage heart tissue, which can trigger a need for more procedures, poor outcomes and higher health care costs .
 
During angioplasty, surgeons insert a balloon catheter to mechanically widen narrowed or obstructed arteries.
 

© AFP 2014

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

CDC Report Reveals How Measles Spreads at Airports

Sunday, 21 Dec 2014 10:23 AM

Traveling through the same U.S. airport gate, one infected passenger transmitted the measles virus to three others withi . . .

Food Pesticide Residue Nothing to Worry About: USDA

Saturday, 20 Dec 2014 10:26 AM

More than half of food tested by the U.S. government for pesticide residues last year showed detectable levels of pestic . . .

Beware of Holiday Allergy Triggers

Saturday, 20 Dec 2014 10:16 AM

The holidays can be anything but joyous for people with allergies when they contend with fresh trees, scented candles an . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved